reglab/statecodes huggingface dataset:
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 385 - MANUFACTURED HOUSING BOARD › Chapter 950 - USED STANDARD - PLUMBING SYSTEMS

Current through 2024-29, July 17, 2024
SUMMARY: This chapter covers the plumbing materials, fixtures,
				and equipment installed within or on manufactured homes. It is the intent of
				this chapter to assure water supply, drain, waste and vent systems which permit
				satisfactory functioning and provide for health and safety under all
				conditions.
General Requirements
A State of Maine licensed plumber shall inspect and verify that
				the following conditions are met. They are:
1. The plumbing is of a durable material,
			 free from defective workmanship that would cause a safety hazard.
2. Water closets are adjusted to use a
			 minimum quantity of water consistent with proper performance and
			 cleaning.
3. All plumbing,
			 fixtures, drains, appurtenances, and appliances designed or used to receive or
			 discharge liquid waste or sewage are connected to the drain system in a manner
			 that is consistent with the State Plumbing Code.
4. All piping and fixtures subject to
			 freezing temperatures shall be insulated or protected to prevent freezing under
			 normal occupancy. To prevent freezing, a modern technological designed heat
			 cable should be used.
5. All
			 dishwashing machines shall not be directly connected to any waste piping, but
			 shall discharge its waste through a fixed air gap installed above the
			 machine.
6. Clothes washing
			 machines shall drain either into a properly vented trap, into a laundry tub
			 tailpiece with watertight connections, into an open standpipe receptor, or over
			 the rim of a laundry tub.
7.
			 Toilets shall be designed and manufactured according to approved or listed
			 standards and shall be equipped with a water flushing device capable of
			 adequately flushing and cleaning the bowl.
8. Each shower stall shall be provided with
			 an approved watertight receptor with sides and back at least 1 inch above the
			 finished dam or threshold.
9. Water
			 supply pumping systems shall be sized to provide an adequate amount of water to
			 each plumbing fixture at a f low rate sufficient to keep the fixture in a clean
			 and sanitary condition without any, danger of backflow or siphonage.
10. Each home shall be equipped with a
			 kitchen sink and bathtub and/or shower and be provided with a hot water supply
			 system including a listed water heater.
11. No part of a water system shall be
			 connected to any drainage or vent piping.
12. All new plumbing after the effective date
			 of these standards shall be lead free with solders and flux containing not more
			 than 0.2 percent lead and pipes and pipe fittings containing not more than 8.0
			 percent lead.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 385 - MANUFACTURED HOUSING BOARD › Chapter 960 - USED STANDARD - HEATING AND FUEL BURNING SYSTEMS

Current through 2024-29, July 17, 2024
SUMMARY: This chapter covers the heating and fuel burning
				equipment installed within, on, or external to a manufactured home.
1. A person holding a master license issued
			 by the State of Maine Oil and Solid Fuel Examining Board shall inspect and
			 certify that the heating and fuel system is in a safe condition and meets the
			 requirements of NFPA-31 Installation of Oil Burning Equipment as adopted by
			 that Board.
2. Heat-producing
			 appliances and vents, roof jacks and chimneys necessary for installation in
			 manufactured homes shall be listed or certified by a nationally recognized
			 testing agency for use in manufactured homes.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 385 - MANUFACTURED HOUSING BOARD › Chapter 970 - USED STANDARD - ELECTRICAL SYSTEM

Current through 2024-29, July 17, 2024
SUMMARY: This chapter covers the electrical conductors and
				equipment installed within or on a home and the conductors that connect the
				home to the supply of electricity.
A person holding a master license issued by the State of Maine
				Electricians Examining Board shall inspect and certify that the electrical
				system that is accessible, including the wiring of the smoke detector, is safe
				and meets the National Electrical Code at the time the home was
				constructed.
A. Homes wired with
			 aluminum conductors shall meet the current Underwriter Laboratory (UL)
			 requirements for connecting to branch circuits of 30 amps or less. (Note: The
			 intent of this is not to require the home to be rewired but only to require
			 that U. L. listed conductors be affixed to receptacle switches and light
			 fixtures. There are several methods of doing this. The most preferred is the
			 "pig tail" method.)
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-A(1) - Affiliated

Current through 2024-29, July 17, 2024
"Affiliated," for purposes of Chapter 35 of the board's
					 rules, means a relationship in which one entity owns 100% of the ownership of
					 both a hospital and a nursing facility or skilled nursing facility.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-1 - Authorized person

Current through 2024-29, July 17, 2024
An "authorized person" is a person other than a pharmacy
					 technician (e.g., computer technician, bookkeeper) who the pharmacist in charge
					 has designated to be present in the prescription filling area in the absence of
					 a pharmacist pursuant to Chapter 13, Section
					 6(8).
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-4 - Blood

Current through 2024-29, July 17, 2024
"Blood" is whole blood collected from a single donor and
					 processed either for transfusion or further manufacturing.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-6 - Central fill pharmacy

Current through 2024-29, July 17, 2024
"Central fill pharmacy" is a pharmacy that prepares
					 prescription drug orders for dispensing pursuant to a valid prescription
					 transmitted to it by a retail pharmacy, rural health center or free clinic; or
					 by a dispensary, hospital pharmacy, extended care facility, boarding home,
					 nursing home, drug abuse treatment center, penal institution, family planning
					 center, medical clinic or any other facility that is not registered or licensed
					 by the board, and returns the labeled and filled prescriptions to the retail
					 pharmacy or other source of origin for delivery to the patient or the
					 authorized agent of the patient.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-7 - Centralized prescription processing

Current through 2024-29, July 17, 2024
"Centralized prescription processing" refers to the
					 functions and activities of a central fill pharmacy and a central processing
					 center. A central fill pharmacy and central processing center may, but need
					 not, operate in the same facility.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-8 - Central processing center

Current through 2024-29, July 17, 2024
"Central processing center" is a pharmacy that performs
					 processing functions including, but not limited to, drug utilization review,
					 claims submission, claims resolution and adjudication, data entry, refill
					 authorizations, interventions and other phone calls for more than one retail
					 pharmacy, rural health center or free clinic; dispensary, hospital pharmacy,
					 extended care facility, boarding home, nursing home, drug abuse treatment
					 center, penal institution, family planning center, medical clinic or any other
					 facility that is not licensed or registered by the board.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-8-A - Certified midwife

Current through 2024-29, July 17, 2024
"Certified midwife" means a midwife certified by and in
					 good standing with the North American Registry of Midwives or the American
					 Midwifery Certification Board, provided that "certified midwife" does not
					 include a certified nurse midwife licensed as an advanced practice registered
					 nurse by the State Board of Nursing.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-10-A - Closed-shop pharmacy

Current through 2024-29, July 17, 2024
"Closed-shop pharmacy" is a pharmacy that purchases drugs
					 for and dispenses drugs to a limited, institutional patient population such as
					 residents of a long term care facility, assisted living program, residential
					 care facility, intermediate care facility for persons with mental retardation,
					 or residential mental health facility.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-11 - Contact hour

Current through 2024-29, July 17, 2024
A "contact hour" is 60 minutes of participation in a
					 continuing professional education activity described in
					  32 MRSA
					 §13735 or Chapter 5 of the board's
					 rules.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-14 - Direct supervision

Current through 2024-29, July 17, 2024
"Direct supervision" is the ability of a pharmacist
					 to:
1. Oversee the activities of a
				  pharmacy intern or pharmacy technician by being physically present within the
				  same work area as the technician being supervised;
2. Direct the activities of a pharmacy intern
				  or pharmacy technician who has no fixed workstation (e.g., visits individual
				  patient rooms); or
3. Oversee the
				  activities of a pharmacy intern or pharmacy technician at a point of care
				  location remote from the pharmacist in control of an automated pharmacy system.
				  Such supervision shall be exercised via 2-way, real-time voice and video
				  communication between the supervising pharmacist and the pharmacy technician.
"Direct supervision" includes activities performed by a
					 pharmacy intern or pharmacy technician during the supervising pharmacist's
					 short-term absence from the workplace for meals or breaks.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-15 - Drug sample

Current through 2024-29, July 17, 2024
"Drug sample" is a unit of a prescription drug that is not
					 intended to be sold and is intended to promote the sale of the drug.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-16 - Electronic device

Current through 2024-29, July 17, 2024
An "electronic device" includes, but is not limited to, a
					 facsimile machine, computer system, portable device, or any other system or
					 equipment approved by the Board.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-17 - Electronic signature

Current through 2024-29, July 17, 2024
"Electronic signature" is an electronic sound, symbol or
					 process attached to or logically associated with a record and executed or
					 adopted by a person with the intent to sign the record.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-17-A - Electronic prescription

Current through 2024-29, July 17, 2024
"Electronic prescription" means a prescription that is
					 generated on an electronic application and transmitted as an electronic data
					 file.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-18-A - Extended hospital pharmacy

Current through 2024-29, July 17, 2024
"Extended hospital pharmacy" means a pharmacy owned by and
					 located in a hospital licensed by the Maine Department of Health and Human
					 Services that is further licensed by the board to dispense drugs as set forth
					 in Chapter 35 of the board's rules.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-19 - FDA

Current through 2024-29, July 17, 2024
"FDA" is the United States Department of Health and Human
					 Services, Food and Drug Administration.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-20 - Hard copy

Current through 2024-29, July 17, 2024
"Hard copy" is a prescription drug order which has been
					 transferred to paper, whether by hand or by equipment, and is readable without
					 the aid of any special devices.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-20-B - Medical oxygen

Current through 2024-29, July 17, 2024
"Medical oxygen" means oxygen in liquid or gaseous form
					 intended for therapeutic use.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-21 - MPJE(r)

Current through 2024-29, July 17, 2024
"MPJE" is the Multistate Pharmacy Jurisprudence
					 Examination.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-22 - NABP(r)

Current through 2024-29, July 17, 2024
"NABP" is the National Association of Boards of
					 Pharmacy.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-23 - NAPLEX(r)

Current through 2024-29, July 17, 2024
"NAPLEX" is the North American Pharmacist Licensure
					 Examination.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-23-A - Non-sterile compounding pharmacy

Current through 2024-29, July 17, 2024
"Non-sterile compounding pharmacy" means a pharmacy that
					 engages in the compounding of drug products in a non-sterile
					 environment.
[NOTE: "Compounding" is defined in
					  32 MRSA
					 §13702-A(4).
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-24 - Nuclear pharmacy

Current through 2024-29, July 17, 2024
"Nuclear pharmacy" is a pharmacy that compounds, stores,
					 dispenses, labels or delivers any radioactive drug.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-25 - Parenteral

Current through 2024-29, July 17, 2024
"Parenteral" means by some other route than through the
					 gastrointestinal tract such as, but not limited to, intravenous, subcutaneous,
					 or intramuscular routes.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-26 - Pharmacist on duty

Current through 2024-29, July 17, 2024
"Pharmacist on duty" is a pharmacist who performs the
					 duties of a pharmacist at any given time.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-27 - Pharmacy intern

Current through 2024-29, July 17, 2024
"Pharmacy intern" is a pharmacy student, recent graduate or
					 foreign graduate engaged in the practice of pharmacy under the direct
					 supervision of a pharmacist while enrolled in the internship program described
					 in Chapter 6-A of the board's rules.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-27-A - Point of care location

Current through 2024-29, July 17, 2024
"Point of care location" means the premises where
					 prescriptions filled by an automated pharmacy system that is not wholly located
					 in a retail pharmacy are delivered or administered.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-28 - Practice setting

Current through 2024-29, July 17, 2024
"Practice setting" includes, but is not limited to, the
					 place, area, site, or manner in which the practice of pharmacy may normally
					 occur or transpire.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-30 - Prescription filling area

Current through 2024-29, July 17, 2024
"Prescription filling area" is the area used for
					 compounding prescription legend drugs, for storing all drugs and devices which
					 may be sold by prescription only, and for any other activities necessary to the
					 practice of pharmacy.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-31 - Printout

Current through 2024-29, July 17, 2024
"Printout" is a hard copy produced by computer that is
					 readable without the aid of any special device.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-32 - Retail pharmacy

Current through 2024-29, July 17, 2024
"Retail pharmacy" is:
1. A pharmacy located in a retail store;
				  or
2. A specialty pharmacy not
				  located in a retail store, including but not limited to a closed-shop pharmacy,
				  sterile compounding pharmacy, extended hospital pharmacy, opioid treatment
				  program and retail supplier of medical oxygen.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-32-A - Retail supplier of medical oxygen

Current through 2024-29, July 17, 2024
"Retail supplier of medical oxygen" means a person who
					 sells or dispenses medical oxygen to a consumer-
1. Pursuant to a prescription from a
				  practitioner; or
2. In
				  circumstances where a prescription is required by federal law.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-33 - Sight-readable

Current through 2024-29, July 17, 2024
"Sight-readable" refers to a record that may be read from
					 a computer screen, microfiche, microfilm, printout, or other method approved by
					 the Board.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-34 - Sterile pharmaceutical

Current through 2024-29, July 17, 2024
"Sterile pharmaceutical" is any dosage form of a drug,
					 including but not limited to, parenterals (e.g., injectables, surgical
					 irrigants, and opthalmics) devoid of viable microorganisms.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-34-A - Sterile compounding pharmacy

Current through 2024-29, July 17, 2024
"Sterile compounding pharmacy" is a pharmacy that engages
					 in the compounding of sterile pharmaceuticals.
[NOTE: "Compounding" is defined in
					  32 MRSA
					 §13702-A(4).]
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-35 - Stop date

Current through 2024-29, July 17, 2024
"Stop date" is the length of time to administer
					 medication. In institutional settings, the physician normally notes the length
					 of time to administer medication on the drug order. In the absence of this
					 notation, the policy of the institution shall determine the length of time
					 various categories of drugs may be administered.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-35-A - VAWD

Current through 2024-29, July 17, 2024
"VAWD" is the Verified-Accredited Wholesale Distributor
					 program administered by NABP.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-36 - Wholesale distribution

Current through 2024-29, July 17, 2024
"Wholesale distribution" is the distribution of
					 prescription drugs by wholesale distributors to persons other than consumers or
					 patients, but does not include:
1.
				  Intra company sales, which include any internal sales transaction or transfer
				  with any division, subsidiary, parent and affiliated or related company under
				  the common ownership and control as the transferor;
2. The purchase or other acquisition by a
				  hospital or other health care entity that is a member of a group purchasing
				  organization of a drug for its own use from the group purchasing organization
				  or from other hospitals or health care entities that are members of such
				  organizations;
3. The sale,
				  purchase or trade of a drug or an offer to sell, purchase or trade a drug by a
				  charitable organization described in section 501(c)(3) of the Internal Revenue
				  Code of 1954 to a nonprofit affiliate of the organization to the extent
				  otherwise permitted by law;
4. The
				  sale, purchase or trade of a drug or an offer to sell, purchase or trade a drug
				  among hospitals or other health care entities that are under common control;
				  for purposes of this section, "common control" means the power to direct or
				  cause the direction of the management and policies of a person or an
				  organization, whether by ownership of stock, voting rights, by contract or
				  otherwise;
5. The sale, purchase or
				  trade of a drug or an offer to sell, purchase or trade a drug for emergency
				  medical reasons; for purposes of this section, "emergency medical reasons"
				  includes transfers of prescription drugs by a retail pharmacy to another retail
				  pharmacy to alleviate a temporary shortage;
6. The sale of a drug by a retail pharmacy to
				  licensed practitioners for office use when the total annual dollar volume of
				  prescription drugs sold to licensed practitioners does not exceed five (5)
				  percent of that pharmacy's total annual prescription drug sales;
7. The sale, purchase or trade of a drug, an
				  offer to sell, purchase or trade a drug, or the dispensing of a drug pursuant
				  to a prescription;
8. The
				  distribution of drug samples by manufacturers' representatives or distributors'
				  representatives;
9. The sale,
				  purchase or trade of blood and blood components intended for transfusion;
				  or
10. Drug returns, when conducted
				  by a hospital, health care entity, or charitable institution in accordance with
				  21 CFR
				  §203.23.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 1 - DEFINITIONS › Section 392-1-1-37 - Wholesale distributor

Current through 2024-29, July 17, 2024
. "Wholesale distributor" is anyone engaged in wholesale
					 distribution of prescription drugs, including, but not limited to,
					 manufacturers; repackers; own-label distributors; private-label distributors;
					 jobbers; brokers; warehouses, including manufacturers' and distributors'
					 warehouses, chain drug warehouses and wholesale drug warehouses; independent
					 wholesale drug traders; and retail pharmacies that conduct wholesale
					 distributions. A wholesale distributor includes a wholesaler as defined in
					  32 MRSA
					 §13702-A(34).
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 2 - ADVISORY RULINGS › Section 392-1-2-1 - Request and Consideration

Current through 2024-29, July 17, 2024
Upon written request of any interested person, the board
					 may issue an advisory ruling pursuant to
					  5 M.R.S.A.
					 §9001 with respect to the applicability
					 of any statute or rule it administers. Requests for advisory rulings must set
					 forth in detail all facts pertinent to the question. The board may decline to
					 issue an advisory ruling if the question is hypothetical, if there is
					 insufficient information upon which to base a ruling, or for any other reason
					 the board deems proper.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 2 - ADVISORY RULINGS › Section 392-1-2-2 - Response

Current through 2024-29, July 17, 2024
The board shall acknowledge receipt of a request for an
					 advisory ruling within 15 days after receipt. The board shall respond to every
					 written request for an advisory ruling within 90 days of its receipt of the
					 request, indicating whether or not a ruling will be issued by the board.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 1 - GENERAL INFORMATION › Chapter 3 - APPLICABILITY OF RULES TO UNREGISTERED FACILITIES › Section 392-1-3-1 - Facilities Not Registered or Licensed by the Board

Current through 2024-29, July 17, 2024
Dispensaries, hospital pharmacies, extended care
					 facilities, boarding homes, nursing homes, drug abuse treatment centers, penal
					 institutions, family planning centers, medical clinics and all other facilities
					 that are not registered or licensed by the board shall comply with and be bound
					 by Chapters 1 - 7 and 14-32 of the board's rules.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4 - LICENSURE OF PHARMACISTS › Section 392-2-4-1 - Applications

Current through 2024-29, July 17, 2024
1.
Generally
The applicant shall complete the application supplied by
					 the board and provide such other information as the board may require.
					 Applications will not be considered for approval until they are complete.
					 Incomplete applications will be returned to the applicant.
2.
Completion of Application
				  Process
An applicant must satisfy all qualifications for licensure
					 in an expeditious manner following submission of the application.
					 Qualifications include but are not limited to the achievement and submission of
					 passing examination scores. Application files that show no activity by the
					 applicant to satisfy the qualifications for licensure over a period of one year
					 will be discarded.
3.
Designation of Examinations
All applicants for licensure must demonstrate passing
					 scores on the NAPLEX and the MPJE or their predecessors, or any successor to
					 either of them recognized by the board.
4.
Applicants for Licensure by
				  Examination
The applicant shall submit with the application-
A. An official transcript from the pharmacy
				  school accredited by the American Council on Pharmaceutical Education or
				  Canadian Council for Accreditation of Pharmacy Programs where the applicant
				  earned a first pharmacy degree. For purposes of this chapter, "accredited"
				  includes pre-candidate and candidate status;
B. Written verification from a regulatory
				  body with jurisdiction over the practice of pharmacy that the applicant has
				  completed an internship that meets the requirements of Chapter 6-A of the
				  board's rules;
C. The fee required
				  by Chapter 10 of the rules of the Department of Professional and Financial
				  Regulation, Office of Professional and Occupational Regulation, entitled
				  "Establishment of License Fees."
A NAPLEX score transfer presented in support of an
					 application for licensure by examination is only valid for one year from the
					 date the applicant achieved the passing score.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4 - LICENSURE OF PHARMACISTS › Section 392-2-4-2 - Term of License

Current through 2024-29, July 17, 2024
All pharmacist licenses expire on December 31 of each
					 year. Licenses may be renewed annually upon completion of a renewal application
					 form supplied by the board and payment of the prescribed fee.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4 - LICENSURE OF PHARMACISTS › Section 392-2-4-3 - Notice of Change of Contact Address

Current through 2024-29, July 17, 2024
A pharmacist shall notify the board of a change of contact
					 address via letter, fax, email or on line within 30 days after the
					 change.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4 - LICENSURE OF PHARMACISTS › Section 392-2-4-4 - Notice of Employment and Non-Employment

Current through 2024-29, July 17, 2024
The board encourages a pharmacist to voluntarily notify
					 the board via letter, fax, email or on line of the pharmacist's commencement or
					 cessation of employment as a pharmacist.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4-A - ADMINISTRATION OF DRUGS AND VACCINES AND OPERATION OF A DRUG OR VACCINE ADMINISTRATION CLINIC INSIDE, OUTSIDE OR OFF THE PREMISES OF A LICENSED RETAIL PHARMACY, RURAL HEALTH CLINIC OR FREE CLINIC › Section 392-2-4-A-1 - Minimum Requirements for Treatment Protocol Issued Pursuant to 32 M.R.S. Section 13833

Current through 2024-29, July 17, 2024
For purposes of this section, a treatment protocol is a
					 written collaborative agreement between a practitioner as described in 32
					 M.R.S. §
										13833 and a pharmacist who holds
					 a certificate of administration or pharmacy as described in this section. A
					 treatment protocol authorizes the administration and injection of drugs and
					 vaccines by a pharmacist who holds a certificate of administration pursuant to
					 32 M.R.S. §§
										13831-13835 and must
					 include, at a minimum, the following provisions:
1.
Authorized Practitioner
The treatment protocol must state the name, professional
					 title, license number and contact information of the authorized practitioner
					 issuing the protocol.
2.
Time Period
The treatment protocol must state the beginning and ending
					 dates of the period of time during which the protocol will be in effect, and
					 the date on which the treatment protocol was issued. The treatment protocol may
					 not have a beginning date prior to the date of issuance.
3.
Scope of Coverage -
				  Pharmacists
The treatment protocol may cover specific, named
					 pharmacists who hold a certificate of administration, or may cover on a blanket
					 basis all pharmacists holding a certificate of administration who are employed
					 by or under contract to a specific pharmacy or pharmacies. Thus, the protocol
					 must either:
A. State the name and
				  contact information of the individual pharmacists holding a certificate of
				  administration who are covered by the treatment protocol; or
B. State the name and physical address of the
				  pharmacy or pharmacies whose employee or contract certified pharmacists holding
				  a certificate of administration will be covered by the treatment protocol
				  without further identification.
A treatment protocol that covers on a blanket basis all
					 pharmacists who hold a certificate of administration and are employed by or
					 under contract to a specific pharmacy or pharmacies only applies to the
					 administration and injection of drugs and vaccines by such pharmacists in the
					 course of the pharmacists' employment or performance of contractual duties for
					 a pharmacy identified in the treatment protocol.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4-A - ADMINISTRATION OF DRUGS AND VACCINES AND OPERATION OF A DRUG OR VACCINE ADMINISTRATION CLINIC INSIDE, OUTSIDE OR OFF THE PREMISES OF A LICENSED RETAIL PHARMACY, RURAL HEALTH CLINIC OR FREE CLINIC › Section 392-2-4-A-2 - Administration Requirements

Current through 2024-29, July 17, 2024
A pharmacist who holds a certificate of administration
					 shall observe the following administration requirements in addition to
					 requirements contained in:
- An applicable prescription, treatment protocol or written
					 standing order issued pursuant to 32 M.R.S. §
										13831(2);
					 and
- The applicable treatment protocol issued pursuant to 32
					 M.R.S. §
										13833 and Section
					 1 of this chapter.
1.
Verification
A. For the administration of all drugs and
				  vaccines pursuant to a prescription or treatment protocol or standing written
				  order, the pharmacist who holds a certificate of administration shall verify:
(1) That the patient is the person to whom
				  the prescription was issued; or
(2)
				  That the patient is a member of the patient population (e.g., employee of
				  designated employer, resident of designated municipality) covered by the
				  treatment protocol or standing written order.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4-A - ADMINISTRATION OF DRUGS AND VACCINES AND OPERATION OF A DRUG OR VACCINE ADMINISTRATION CLINIC INSIDE, OUTSIDE OR OFF THE PREMISES OF A LICENSED RETAIL PHARMACY, RURAL HEALTH CLINIC OR FREE CLINIC › Section 392-2-4-A-4 - Administration of Drugs and Vaccines by Pharmacy Intern

Current through 2024-29, July 17, 2024
A pharmacy intern who is under the direct supervision of a
					 pharmacist holding a certificate of administration and has obtained the drug
					 administration training required by 32 M.R.S. §
										13832(3) may
					 administer drugs and vaccines.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 4-A - ADMINISTRATION OF DRUGS AND VACCINES AND OPERATION OF A DRUG OR VACCINE ADMINISTRATION CLINIC INSIDE, OUTSIDE OR OFF THE PREMISES OF A LICENSED RETAIL PHARMACY, RURAL HEALTH CLINIC OR FREE CLINIC › Section 392-2-4-A-5 - Scope of this Chapter

Current through 2024-29, July 17, 2024
The provisions of this chapter apply to drugs and vaccines
					 that may be administered pursuant to 32 M.R.S. §
										13831.
The provisions of this chapter do not apply to prescribing,
					 administering, or dispensing HIV prevention drugs pursuant to 32 M.R.S. §
										13786- E.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 5 - CONTINUING PHARMACY EDUCATION › Section 392-2-5-1 - Continuing Education Requirement

Current through 2024-29, July 17, 2024
All pharmacists other than newly-licensed pharmacists
					 shall complete 15 contact hours of continuing pharmacy education annually as
					 set forth in this chapter.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 5 - CONTINUING PHARMACY EDUCATION › Section 392-2-5-2 - Newly-Licensed Pharmacists

Current through 2024-29, July 17, 2024
All pharmacists who obtain an initial license to practice
					 pharmacy in Maine by examination or by reciprocity shall complete 1.25 hours of
					 continuing pharmacy education for each month following initial licensure
					 through December 31 of the calendar year in which they were initially
					 licensed.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 5 - CONTINUING PHARMACY EDUCATION › Section 392-2-5-3 - Processing of Requests For Exceptions

Current through 2024-29, July 17, 2024
Requests for exceptions to the requirement of 15 hours of
					 continuing pharmacy education made pursuant to
					  32 M.R.S.A.
					 §13735 (active licensees) or
					  32 M.R.S.A.
					 §13734(2) (nonactive
					 licensees) shall be decided by the continuing education committee established
					 pursuant to
					  32 M.R.S.A.
					 §13735.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 5 - CONTINUING PHARMACY EDUCATION › Section 392-2-5-5 - Reinstatement

Current through 2024-29, July 17, 2024
No license will be issued to a pharmacist applying for
					 reinstatement within 2 years of expiration unless the applicant has completed
					 15 hours of continuing pharmacy education in the 12 months prior to
					 application.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 5 - CONTINUING PHARMACY EDUCATION › Section 392-2-5-6 - Appeal

Current through 2024-29, July 17, 2024
A pharmacist may appeal a final decision of the continuing
					 education committee to the board by filing a request for hearing with the board
					 within 30 days of the pharmacist's receipt of the committee decision from which
					 appeal is taken. An adjudicatory hearing will be scheduled upon receipt of a
					 timely appeal. Non-timely appeals will be denied without hearing.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6 - PHARMACY STUDENT INTERNSHIP PROGRAMS (SUNSETTED)

Current through 2024-29, July 17, 2024
Summary:
This chapter sets forth requirements of
				  the pharmacy student internship required for licensure by Chapter 4, Section
				  1(4)(B) of the board's rules.
[repealed]
STATUTORY AUTHORITY:
					  32 M.R.S.A.
					 §§13720 ,
					 13721(1)(G)
					 ,
					 13723
					 ,
					 13732(3)
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-1 - Scope

Current through 2024-29, July 17, 2024
The provisions of this subchapter apply to pharmacy
						internships for pharmacy students educated in pharmacy schools accredited by
						the Accreditation Council for Pharmacy Education (United States) or the
						Canadian Council for Accreditation of Pharmacy Programs (Canada), or a
						successor organization. For purposes of this chapter, "accredited" includes
						precandidate and candidate status.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-2 - Student Internship Program

Current through 2024-29, July 17, 2024
The pharmacy student internship consists of an IPPE and
						APPE administered by one or more pharmacy schools accredited by the
						Accreditation Council for Pharmacy Education, the Canadian Council for
						Accreditation of Pharmacy Programs, or a successor organization. The internship
						must be completed as part of the professional curriculum leading to the Doctor
						of Pharmacy degree. The minimum duration of the IPPE and APPE combined is 1,500
						hours.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-3 - Application for Licensure as a Pharmacy Intern

Current through 2024-29, July 17, 2024
A student matriculated in a professional academic
						program leading to the Doctor of Pharmacy degree shall apply to the board for
						licensure as a pharmacy intern prior to commencement of an IPPE or APPE in
						Maine. A student may not participate in either pharmacy practice experience
						until the board has actually issued a pharmacy intern license to the student.
						It is the student's obligation to at all times be aware of his or her licensure
						status. To apply, the pharmacy student shall:
1. Complete the application supplied by the
					 board;
2. Provide the verifications
					 required by Section 4 of this subchapter;
3. Remit the fee required by Chapter 10 of
					 the rules of the Department of Professional and Financial Regulation, Office of
					 Professional and Occupational Regulation, entitled "Establishment of License
					 Fees;" and
4. Provide such other
					 information as the board may require.
Applications will not be considered for approval until
						they are complete. Applications that remain incomplete for more than 60 days
						will be discarded.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-4 - Qualifications for Licensure

Current through 2024-29, July 17, 2024
1.
Matriculation
As part of the application, the applicant shall present
						to the board written verification of matriculation in a professional academic
						degree program described in Section 2 of this subchapter. Maintenance of
						matriculation is an ongoing requirement of licensure. A license issued under
						this chapter automatically terminates upon a student's dropping out of or
						expulsion from pharmacy school.
2.
Disciplinary History; Criminal
					 Convictions Involving Controlled Substances
The applicant shall supply verification of licensure or
						registration for all states in which the applicant has at any time held any
						type of professional or occupational license. The board may refuse to license
						and may refuse to renew the license of an applicant:
A. Whose professional or occupational license
					 or registration has been denied, revoked, suspended or restricted in any
					 jurisdiction for disciplinary reasons; or
B. Who has been convicted of a crime
					 involving alcohol or drugs. This restriction is subject to consideration and
					 waiver by the board upon presentation of satisfactory evidence that the
					 conviction does not impair the ability of the person to conduct, with safety to
					 the public, the duties of a pharmacy intern.
[NOTE: The effect of a criminal conviction on an
						applicant's eligibility for licensure is governed generally by the Occupational
						License Disqualification on Basis of Criminal Record law,
						5 MRSA
						§5301 et seq.]
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-5 - Issuance and Renewal of License

Current through 2024-29, July 17, 2024
The initial license and all renewal licenses expire on
						December 31 annually. The license may be renewed for successive 1-year periods
						upon completion of a renewal application supplied by the board and
						certification by the licensee that he or she continues to be enrolled in a
						professional academic degree program as described in Section 1 of this
						subchapter. There is no fee to renew the license. A licensee who fails to
						timely renew the license must apply for a new pharmacy intern license and pay a
						reinstatement fee. A pharmacy intern may not practice with an expired or
						invalid license.
Code of Maine Rules › 02 - DEPARTMENT OF PROFESSIONAL AND FINANCIAL REGULATION › 392 - MAINE BOARD OF PHARMACY › Part 2 - LICENSES AND REGISTRATIONS › Chapter 6-A - PHARMACY STUDENT INTERNSHIP PROGRAMS › Subchapter 1 - PHARMACY INTERNS EDUCATED IN PHARMACY SCHOOLS ACCREDITED BY THE ACCREDITATION COUNCIL FOR PHARMACY EDUCATION OR CANADIAN COUNCIL FOR ACCREDITATION OF PHARMACY PROGRAMS › Section 392-2-6-A-1-6 - Final Renewal Period; Expiration

Current through 2024-29, July 17, 2024
The licensee shall notify the board of the licensee's
						graduation within 10 days as required by
						
						10 MRSA §8003-G(2)(D).
						A pharmacy intern license automatically expires on the second renewal
						subsequent to the licensee's graduation and may not be further renewed. The
						licensee shall also notify the board within 10 days if the licensee has dropped
						out of or been expelled from pharmacy school.